SLDB

AcronymDefinition
SLDBSea Lion Defense Brigade
SLDBSarawak Land Development Board (est. 1972; Malaysia)
SLDBSri Lanka Development Bond
SLDBState Land Development Bank (India)
SLDBSerial Link Daughter Board (computing)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
SLDB scores are believed to match WISC-R scores with certain patterns (22,23,24).
The land bank is then surrendered to the managing agents, either to the Land Consolidation Development Authority (LCDA) and/or to the Sarawak Land Development Board (SLDB), which acts as the trustee for the NCL.
SilverPlatter predicts the SLDB file will grow to well over a million links by the end of 1999.
It should be developed, put to good use, do not just plant oil palm, diversify to other crops such as durians, pomelos, and other fruits which have a high demand,' he said at the ceremony to hand over the SLDB land titles and individual customary land titles here.
And while Pfizer believes complement activation was driven by a high presence of neutralizing antibodies, the serious adverse event was also observed with Solid Biosciences' (SLDB) gene therapy, which employs the same vector as Pfizer, adds the analyst.
The Court of Appeal today upheld the acquittal of former Sabah Land Development Board (SLDB) general manager Datuk Wasli Mohd Said on bribery charges involving RM1 million in 2006.
Following the near 100% rally in shares of Solid Biosciences Inc (NASDAQ: SLDB) in August, one Citigroup analyst said the stock price is diverging from worsening fundamentals.
Shares of both Sarepta (SRPT) and Solid Biosciences (SLDB) have been volatile in early trading after Pfizer (PFE) presented "preliminary data drawn from a small number of participants" in an ongoing Phase 1b study of PF-06939926, an investigational gene therapy to potentially treat Duchenne muscular dystrophy, or DMD.
* Solid Biosciences Inc.(NASDAQ: SLDB) tumbled 10.2% to $8.16 after Citigroup downgraded the company's stock from Neutral to Hold and set a $6 price target.
Solid Biosciences (SLDB) downgraded to Underperform from Neutral at Credit Suisse, to Sell from Neutral at Goldman Sachs, and to Neutral from Buy at Chardan.